Insider screener

Period: 12 months Role: Other officers × Minimum amount: $100K × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

14,309 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

14,309 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

14,309 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

14,309 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
14,309 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
14,309 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

14,309 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
24 Nov 2025
Bradley K Serwin General Counsel
Sold on a plan
$220.00K 20,952 at 10.50
7.0%
Planned (10b5-1)
24 Nov 2025
Jeffrey Buckley See Remarks
Sold on a plan
$197.19K 1,252 at 157.50
2.6%
Planned (10b5-1)
24 Nov 2025
David H. Sampsell VP, Corp. Dev, GC & Corp. Sec.
Sold at will
$189.08K 4,727 at 40.00
0.0%
Not planned
24 Nov 2025
Ali Dasdan Chief Technology Officer
Sold on a plan
$169.98K 5,666 at 30.00
1.1%
Planned (10b5-1)
24 Nov 2025
Global GP LLC General Partner
Bought
$166.73K 3,965 at 42.05
2.1%
24 Nov 2025
Benjamin J. Hindson See Remarks
Sold at will
$157.36K 8,283 at 19.00
1.9%
Not planned
24 Nov 2025
Joseph A. Kimmell EVP, Operations
Sold at will
$148.66K 1,812 at 82.04
3.1%
Not planned
24 Nov 2025
Suren Gupta President,Enterprise Solutions
Sold on a plan
$129.01K 600 at 215.02
0.6%
Planned (10b5-1)
24 Nov 2025
Alan D Gold Executive Chairman · indirect
Bought
$127.63K 2,600 at 49.09
opened
Largest buy in 3 yrs
24 Nov 2025
Leonard M Tannenbaum Executive Chairman
Bought
$126.36K 13,000 at 9.72
0.4%
24 Nov 2025
Yvonne K. Franzese Chief Human Resources Officer
Sold on a plan
$123.00K 3,000 at 41.00
12.2%
Planned (10b5-1)
24 Nov 2025
Spencer Davidson Chairman
Bought
$102.92K 4,120 at 24.98
2.4%
24 Nov 2025
David Raben Chief Medical Officer
Sold on a plan
$101.48K 5,500 at 18.45
13.4%
Planned (10b5-1)
21 Nov 2025
Alexander C. Karp See Remarks
Sold at will 3×
$7.12M 45,564 at 156.25
0.7%
Not planned
21 Nov 2025
Stephen Andrew Cohen See Remarks
Sold at will 3×
$6.12M 39,136 at 156.25
98.5%
Sold half or more
21 Nov 2025
Keith Rupert Murdoch Chairman Emeritus · indirect
Sold at will
$5.93M 100,000 at 59.26
8.3%
Not planned
21 Nov 2025
Sharon Benzeno Chief Commercial Ofc Imm Med
Sold on a plan
$5.22M 308,477 at 16.91
51.0%
Sold half or more
21 Nov 2025
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 4×
$4.82M 25,641 at 188.13
51.1%
Sold half or more
21 Nov 2025
Suren Gupta President,Enterprise Solutions
Sold on a plan
$4.71M 21,871 at 215.21
17.9%
Planned (10b5-1)
21 Nov 2025
Lei Zhang Schlitz VP & Pres, Global Products
Sold at will
$3.63M 32,031 at 113.20
32.4%
Not planned
21 Nov 2025
Xinyan Hao Chief Operating Officer · indirect
Sold on a plan
$3.52M 100,000 at 35.18
19.7%
Planned (10b5-1)
21 Nov 2025
J Patrick Doyle Executive Chairman
Sold at will 3×
$3.04M 43,597 at 69.80
18.4%
Not planned
21 Nov 2025
Shyam Sankar See Remarks
Sold at will 3×
$2.97M 19,004 at 156.25
2.9%
Not planned
21 Nov 2025
Christos Dimopoulos Executive VP, Global Markets
Sold at will 2×
$2.39M 25,300 at 94.37
19.5%
Not planned
21 Nov 2025
Fred P. Lampropoulos Executive Chairman
Sold at will
$2.18M 25,000 at 87.31
2.4%
Not planned
21 Nov 2025
Marshall S. Stanton SVP, Clinical & MD Affair
Sold at will 4×
$2.13M 47,376 at 45.04
51.4%
Sold half or more
21 Nov 2025
Rajat Taneja President, Technology
Sold on a plan
$2.08M 6,305 at 330.00
2.6%
Planned (10b5-1)
21 Nov 2025
David Zapolsky Senior Vice President
Sold on a plan 5×
$1.54M 7,100 at 216.94
11.5%
Planned (10b5-1)
21 Nov 2025
Joseph D Mansueto Executive Chairman
Sold on a plan 5×
$1.53M 7,250 at 211.22
0.1%
Planned (10b5-1)
21 Nov 2025
John Swieringa Pres, Tech & COO
Sold at will
$1.48M 22,000 at 67.34
7.2%
Not planned
21 Nov 2025
David Donnay Rowland EVP & Co-Chief Invest. Officer
Sold at will
$1.45M 5,000 at 290.57
22.2%
Not planned
21 Nov 2025
Jeff B Gustavson Vice President
Sold at will
$1.40M 9,325 at 150.27
84.8%
Sold half or more
21 Nov 2025
Julia Madsen Sr. VP and GM, Life Sciences
Sold at will 2×
$1.31M 5,008 at 262.00
31.9%
Not planned
21 Nov 2025
Patrick J. Haley EVP, Commercial
Sold at will
$1.19M 28,043 at 42.58
7.0%
Not planned
21 Nov 2025
Arun Pinto Chief Risk Officer
Sold on a plan
$1.14M 46,132 at 24.76
25.0%
Planned (10b5-1)
21 Nov 2025
Amy D. Husted Exec VP General Counsel & Sec
Sold at will
$1.12M 10,413 at 107.42
47.0%
Not planned
21 Nov 2025
Carole Huntsman Chief Commercial Officer
Sold on a plan 11×
$1.08M 1,958 at 553.11
16.3%
Planned (10b5-1)
21 Nov 2025
Ignacio A Cortina EVP, CL&AO & Secretary
Sold at will
$995.28K 8,000 at 124.41
15.0%
Not planned
21 Nov 2025
Helga Houston Senior Exec. V. P.
Sold at will
$993.35K 64,587 at 15.38
10.8%
Not planned
21 Nov 2025
Sam Bryan Cook Executive Chairman
Bought
$811.00K 38,619 at 21.00
opened
First buy on file
21 Nov 2025
Paul D Fabara Chief Risk & Client Svcs Ofc
Sold on a plan
$707.92K 2,172 at 325.93
7.6%
Planned (10b5-1)
21 Nov 2025
James Pursley President
Sold at will 3×
$683.49K 15,000 at 45.57
1.9%
Not planned
21 Nov 2025
Owen Britton Jennings Business Lead
Sold at will
$639.60K 10,417 at 61.40
4.1%
Not planned
21 Nov 2025
Shelley Reynolds Vice President
Sold on a plan 3×
$583.22K 2,695 at 216.41
2.2%
Planned (10b5-1)
21 Nov 2025
William H Heyman Vice Chairman
Sold at will 2×
$583.00K 2,000 at 291.50
0.8%
Not planned
21 Nov 2025
Dunson K Cheng Executive Chairman
Sold at will
$478.52K 10,000 at 47.85
6.4%
Not planned
21 Nov 2025
Sylebra Capital LLC See Footnotes · indirect
Sold at will
$472.43K 3,046 at 155.10
0.2%
Not planned
21 Nov 2025
Alberto Horihuela Chief Operating Officer
Sold on a plan
$438.74K 138,753 at 3.16
8.1%
Planned (10b5-1)
21 Nov 2025
Arnaud Weber Engineering Lead
Sold at will
$435.63K 7,095 at 61.40
2.7%
Not planned
21 Nov 2025
Peter Platzer Executive Chairman
Sold on a plan
$415.88K 54,793 at 7.59
3.5%
Planned (10b5-1)
Showing 13,401–13,450 of 14,309. ← Newer Page 269 of 287 Older →